| INTRODUC TI ON
More than one in 10 women undergo pelvic organ prolapse (POP) surgery in their lifetime. 1, 2 In Finland, the lifetime likelihood of POP surgery is 13%, and approximately 4200 operations are performed annually. 3, 4 There are numerous methods used for POP surgery.
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Clinicians must choose between vaginal and abdominal surgical approaches, decide whether to use native tissue or a surgical mesh, choose to repair one or multiple sites of prolapse, and decide whether concomitant surgery, such as hysterectomy or incontinence surgery, is necessary. The operative method depends on the nature, site and severity of the prolapse and the symptoms affecting urinary, bowel or sexual function. 6 The patient's general health and individual needs and values should be considered when determining the operative method. 7, 8 There continues to be a limited level of evidence to guide clinicians in choosing the best surgical technique for a particular patient. 7 Furthermore, a surgeon's own preferences and capabilities influence the decision. There is significant heterogeneity (>10-fold)
in the rates at which individual POP procedures are performed in different countries. 9 Recently, the risks related to mesh augmentation have caused debate regarding the safety of this method for POP surgery. 10 Thus, different surgical techniques and their safety and effectiveness require further assessment.
This nationwide prospective annual cohort study reports the methods used for POP surgery in Finland in 2015. The patient characteristics and symptoms were compared between women who were treated with native tissue repair (NTR), a vaginal mesh (TVM) or an abdominal mesh (AM) augmentation to identify the factors that affect clinicians' choice to use a mesh instead of NTR for POP surgery.
| MATERIAL AND ME THODS
All Finnish hospitals that performed POP surgery in 2015 were invited to participate in this nationwide prospective multicenter study. The study was organized by the Finnish Society for Gynecological Surgery, and the study protocol of a national multicenter study with local doctors in charge was similar to a previous study of hysterectomies (FINHYST 2006) . 11 The study period was between 1 January 2015 and 31 December 2015. We retrieved the actual total number of POP operations performed in Finland during this period from the Finnish Hospital Discharge Register of the National Institute for Health and
Welfare. 4 The inclusion criteria for the patients were age older than 18 years and ability to communicate in written and oral Finnish or Swedish. Written informed consent was obtained from each patient.
The surgical treatment and patient characteristics were derived from questionnaires filled out by both doctors and patients. The usefulness and reliability of the questionnaires (paper and electronic forms) and the study protocol were tested in a pilot study performed in 2014 at Tampere University Hospital, Central Finland Central
Hospital and Kanta-Häme Central Hospital. The data from the pilot study are not included in this analysis.
The surgeons completed an electronic study questionnaire. The degree of prolapse was assessed using a simplified Pelvic Organ
Prolapse Quantification (POPQ) system. 6 The surgeons recorded the single most distal Pelvic Organ Prolapse Quantification point of all three compartments of the vagina (anterior, posterior or apical) in centimeters from the hymen. They also documented the operative method with a description and a code from the Nordic Classification of Surgical Procedures (NCSP).
The participants completed a questionnaire in either an electronic or paper form based on their own preferences. 
| Statistical analyses
The operations were categorized into three groups: NTR, transvaginal mesh augmentation (TVM) and abdominal mesh (AM) augmentation. Patient characteristics and surgical details were analyzed in the whole study population and in each surgical method group. The statistical significance was set at P < 0.05. The differences in categorical variables between the surgery groups were tested with the χ 2 test.
Q-Q-plots were used to assess the distribution of continuous variables, and Levene's test was used to assess the equality of variances in the different groups. When the variances were equal, the differences among continuous variables between the groups were tested with an analysis of variance, and the Bonferroni method was applied to assess pairwise comparisons. For variables with unequal variance, the BrownForsythe test was used to assess the differences between the groups, and Dunnett's T3 was used to assess pairwise differences. The patient characteristics are given in Table 1 . The patients who underwent TVM were significantly older, less sexually active and more likely to have cardiovascular diseases or be treated with medication for chronic disease than patients in the other groups
| Ethical approval
were. There was no significant difference in the proportion of obese patients between the groups. The participants' smoking habits and parity did not differ between groups. Altogether, 1701 (48%) patients had a history of previous pelvic surgery. The total previous hysterectomy rate was 79% for the TVM, 76% for the AM and 23%
for the NTR groups (P < 0.001). A total of 891 (25%) patients had undergone previous surgery for POP; all these patients were symp- Table 2 . The highest total PFDI-20 scores were observed in the mesh groups, indicating greater distress due to symptoms.
In the AM group, the average score was 10 points (95% confidence Vaginal deliveries, median (min -max)
Cesarean sections, median (min -max)
No deliveries, n (%) The factors affecting the use of a mesh are described in Table 3 .
The strongest predictor for the use of a mesh was a previous POP surgery of the same vaginal compartment (odds ratio [OR] 56 for TVM and 22 for AM). Other predictive factors were previous hysterectomy and severe bulge symptoms. TVM was associated with advanced anterior prolapse, whereas AM augmentation was associated with advanced apical and posterior prolapse. Regional differences in practices were found. The patient's healthcare district was a strong predictor of the use of mesh surgery; there was almost a 10-fold difference between the highest and lowest OR for the use of a transvaginal mesh.
The hospital level did not explain the variation in the use of a mesh.
A total of 2644 (75%) operations were performed for patients without prior prolapse surgery, 92% of these performed using na- CRADI-8, colorectal-anal distress inventory with eight questions concerning difficulties of defecation; POPDI-6, pelvic organ prolapse distress inventory of six questions about the inconvenience of the prolapse; UDI-6, urinary distress inventory with six questions about difficulties in urination. Data were derived from filled in questionnaires for analysis of PFDI-20 scores (n = 2903). a P-value was for the difference between the three different surgical modalities (NTR, native tissue repair; TVM, transvaginal mesh; AM, abdominal mesh).
of hospital did not affect the risk of primary TVM, but there was significant variation in the practices between hospitals (Appendix S1).
Risk factors for TVM as the primary surgery were advanced anterior or apical prolapse, bothersome bulge symptoms and healthcare district (Table 3 ). An AM augmentation was more often used as the primary surgery for patients with rectal intussusception (OR = 20.1, 95% CI 12.9-31.6). Other predictive factors were advanced apical or posterior compartment prolapse. Previous hysterectomy was a risk factor for both transvaginal mesh and AM use during the primary surgeries.
| D ISCUSS I ON
This nationwide prospective cohort study of 3535 operations showed that 81% of all patients and 92% of patients without prior prolapse surgery underwent vaginal native tissue reconstruction.
The strongest predictors for the use of a mesh were recurrent POP, previous hysterectomy, healthcare district and severe bulge symptoms. TVM was associated with advanced anterior prolapse and older age. AM augmentation surgery was associated with advanced apical and/or posterior compartment prolapse; the highest total PFDI-20 scores indicated more bothersome symptoms than in the other groups. The median preoperative symptom scores were at the same level as in studies with selected patient groups, suggesting that the indications for POP surgery in Finland are comparable to those discussed in other reports. 15, 16 The overall rate of POP surgery in Finland in 2015 was 1.5 per 1000 women, which is comparable to the results of a study of 15
other Organisation for Economic Co-operation and Development (OECD) countries in 2012. 9 The data from other Nordic countries showed that the rate of POP surgery per 1000 women was 2.0 in Sweden and 1.8 in Denmark in 2012. 9 The rate of TVM was 0.19 and that of AM augmentation 0.048 per 1000 women in OECD countries, 9 whereas in the present study, the rates were 0.15 and 0.090 per 1000 women, respectively. This finding indicates that transvaginal mesh augmentation was used moderately in Finland during the study period. In comparison, in 2012, the rate of TVM per 1000 women was 0.37 in Sweden and 0.07 in Denmark, which was considerably higher in Sweden and lower in Denmark than the rate in the present study. Furthermore, the rate of sacral colpopexy per 1000 women was 0.015 in Sweden and 0.006 in Denmark both much lower figures than in Finland. 9 Unlike in Denmark, mesh augmentations are not centralized in Finland and Sweden, which may partly explain the higher mesh surgery rates than in Denmark. However, regional differences in POP surgical methods in Nordic countries have not been reported previously. We observed significant regional variation in the use of mesh augmentation. For transvaginal mesh surgery, this variation was almost 10-fold. This finding may be partly due to differences in the population, but it does imply different practices between hospitals. According to recent European recommendations, mesh augmentations should only be carried out by surgeons with appropriate training who are working in multidisciplinary referral centers.
17
Recurrence of prolapse is common. Over 1-3 years of follow up after NTR, 38% of the patients had a recurrent prolapse on examination, and 19% were aware of this prolapse. 18 In the present study, 25% of the patients had undergone previous surgery for POP, and 17% of the patients had a recurrence in the same vaginal compartment. This finding suggests a moderate recurrence rate after POP surgery in Finland. Relatively few Manchester and obliterative procedures compared with vaginal hysterectomies were performed. In a Danish cohort study, vaginal hysterectomy was associated with a higher recurrence rate than the Manchester procedure, and this method of apical prolapse surgery should be considered if there is no indication for hysterectomy.
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The indications for the use of a mesh during POP surgery have been widely debated after the Food and Drug Administration (FDA)
of the USA provided a second warning on the adverse effects of TVM surgery in 2011. 10 The rate of TVM surgery has diminished dramatically 20, 21 and in some countries, transvaginal mesh use has been abandoned. 22 After the 2015 study period, most commercial transvaginal mesh kits were withdrawn from the market, and the rate of TVM surgery decreased in Finland. 4 Nevertheless, after critical evaluation and based on patient information, transvaginal mesh augmentation remains an option for patients with a high risk of prolapse recurrence. 8, 18 In randomized studies, vaginal mesh augmentation has provided anatomic benefits and decreased prolapse awareness but is associated with higher rates of de novo stress urinary incontinence, bladder injury and reoperations compared with NTR. 18, 23 Eight percent of patients require repeat surgery due to transvaginal mesh exposure. In the present study, a recurrent POP in the same vaginal compartment was the strongest predictive factor for the use of a mesh.
This finding is in line with recent recommendations. 8, 17 For primary prolapse, the use of a synthetic mesh is controversial and studies do not support using TVM in anterior or posterior compartment repair.
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In a Scottish retrospective cohort study of 18 986 women, 7% of the primary operations were mesh surgeries. 25 In our study, a similar number of primary POP operations were mesh operations. Posterior compartment prolapse was a protective factor for TVM and this finding is in line with recommendations to avoid the use of a mesh with these patients. 8 Advanced anterior prolapse is more prevalent and more prone to failure after repairs; thus, synthetic mesh may be beneficial. 8 In the present study, advanced anterior prolapse was a predictive factor for TVM. Advanced apical and posterior compartment prolapse and rectal intussusception were predictive factors for AM augmentation, also in accordance with the recommendations.
7
Previous hysterectomy was a strong predictive factor for mesh augmentation. This finding is in line with those of previous studies supporting the assumption that hysterectomy increases the risk of later POP surgery, especially posterior compartment prolapse repair. 26, 27 Our study has some limitations. The participation rate varied between hospitals, which may bias the comparison of treatment practices between hospitals. We did not record the socioeconomic or menopausal status of the patients. The surgical method was based on an individual surgeon's assessment and preferences, and the surgeons were not aware of the symptom scores reported on the forms completed by the patients; this may be a limitation but, on the other hand, reflects normal practice. Notably, 3% of the patients underwent vaginal hysterectomy alone. This finding may be due to a coding error or a practice pattern, but because of the nature of the study, we could not draw any further conclusions on how vaginal cuff suspension was performed in these cases.
The strength of our study is that this nationwide prospective cohort covered the majority of all POP operations performed in Finland, offering a holistic picture of practices within a country. The study protocol also included clinicians' assessments of the preoperative situation and validated health-related quality of life questionnaires.
The previous large cohort studies were mainly based on retrospective databases and did not use symptom questionnaires.
25,28

| CON CLUS ION
The practices reported here follow international recommendations that consider NTR to be the principal surgical method for POP surgery. 17, 18 A synthetic mesh was mainly used in complex cases with recurrent prolapse in the same compartment. However, there was regional variation between the rates of mesh augmentation for POP surgery. In our opinion, this implies a general lack of sufficient evidence regarding the most suitable treatment methods for POP and indicates a need for national guidelines.
